Vycor Medical Inc
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive co… Read more
Vycor Medical Inc (VYCO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.018x
Based on the latest financial reports, Vycor Medical Inc (VYCO) has a cash flow conversion efficiency ratio of 0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-72.43K) by net assets ($-4.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vycor Medical Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Vycor Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vycor Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vycor Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CREALOGIX HLDG N
MU:CX1
|
-0.187x |
|
Century Global Commodities Corp
PINK:CEUMF
|
0.017x |
|
CASELLA WASTE SYS-A
BE:WA3
|
0.060x |
|
KAWASAKI HEAVY IND - Dusseldorf Stock Exchang
DU:KHE
|
0.198x |
|
LABOCANNA S.A. ZY-10
F:9Y2
|
N/A |
|
PolyPlank publ AB
ST:POLY
|
0.323x |
|
AB Linas
MU:YCJ
|
0.025x |
|
WYNN RESORTS - Dusseldorf Stock Exchang
DU:WYR
|
-0.262x |
Annual Cash Flow Conversion Efficiency for Vycor Medical Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Vycor Medical Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-3.69 Million | $60.11K | -0.016x | -84.07% |
| 2023-12-31 | $-3.33 Million | $29.43K | -0.009x | -111.99% |
| 2022-12-31 | $-2.94 Million | $-217.02K | 0.074x | +927.13% |
| 2021-12-31 | $-2.40 Million | $21.37K | -0.009x | -107.10% |
| 2020-12-31 | $-1.98 Million | $-248.79K | 0.126x | +2725.22% |
| 2019-12-31 | $-1.35 Million | $-6.02K | 0.004x | -98.69% |
| 2018-12-31 | $-768.83K | $-260.32K | 0.339x | +105.23% |
| 2017-12-31 | $81.44K | $-527.44K | -6.476x | -134.46% |
| 2016-12-31 | $-26.44K | $-496.92K | 18.796x | +1944.50% |
| 2015-12-31 | $1.15 Million | $-1.17 Million | -1.019x | -9.00% |
| 2014-12-31 | $2.89 Million | $-2.70 Million | -0.935x | -- |